Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Secular Trends of Blood Stream Infections in the 72 Hours Prior to Death in Allogeneic Hematopoietic Cell Transplant Recipients

Shylaja Mani, MD, Lisa A. Rybicki, MS, Navneet S. Majhail, MD MS, Sherif Mossad, MD

Blood (2014) 124 (21): 3891.

https://doi.org/10.1182/blood.V124.21.3891.3891

Published: 2014

Journal Articles

The Worth of Surveillance for Vancomycin-Resistant Enterococci in the Hematology-Oncology Unit

Marcelo Bellesso, MD, Edson Abdala, PhD, Juliana Pereira, PhD, Rodrigo Santucci, MD, Karim Yaqub Ibrahim, PhD, Maristela Pinheiro Freire, MSc, Lumena Vaz Carvalho Fratelli, RN, Patricia Andréa Crippa Marques

Blood (2014) 124 (21): 6009.

https://doi.org/10.1182/blood.V124.21.6009.6009

Published: 2014

Journal Articles

Vancomycin-Resistant Enterococcus (VRE) Bacteremia During Acute Myeloid Leukemia (AML) Induction Therapy Is an Independent Predictor of Poor Outcome

Moshe Ornstein, MD, MA, Sudipto Mukherjee, MD PhD, Michael K. Keng, MD, Paul Elson, ScD, Ramon V. Tiu, MD, Yogenthiran Saunthararajah, MD, Leslie Farhat, Diane Banks, Anjali Advani, MD, Matt Kalaycio, MD, Jaroslaw P. Maciejewski, MD, PhD, Mikkael A. Sekeres, MD, MS

Blood (2012) 120 (21): 1487.

https://doi.org/10.1182/blood.V120.21.1487.1487

Published: 2012

Journal Articles

Risk Factors for Vancomycin Resistant Enterococcus (VRE) Infection and Its Influence On Survival After Allogeneic Hematopoietic Progenitor Cell Transplantation (aHPCT)

Maia Tavadze, MD, Sherif Mossad, MD, Lisa Rybicki, MS, Robin Avery, MD, Melissa Yurch, Brad Pohlman, MD, Hien K. Duong, MD, Robert M Dean, MD, Brian T. Hill, MD, PhD, Steven Andresen, DO, Rabi Hanna, MD, Edward A. Copelan, MD, Brian J. Bolwell, MD, Matt Kalaycio, MD, Ronald Sobecks, MD

Blood (2012) 120 (21): 4147.

https://doi.org/10.1182/blood.V120.21.4147.4147

Published: 2012

Journal Articles

Early Cessation of a Vancomycin-Resistant Enterococci (VRE) Outbreak in a Hematology-Oncology Department after Implementation of an Enhanced Infection Control Intervention. A Single Center Experience.

Andrew J. Ullmann, MD, Thomas Fischer, MD, Bernd Jansen, MD, PhD, Christoph Huber, MD

Blood (2004) 104 (11): 2209.

https://doi.org/10.1182/blood.V104.11.2209.2209

Published: 2004

NARROW

Secular Trends of Blood Stream Infections in the 72 Hours Prior to Death in Allogeneic Hematopoietic Cell Transplant Recipients

The Worth of Surveillance for Vancomycin-Resistant Enterococci in the Hematology-Oncology Unit

Vancomycin-Resistant Enterococcus (VRE) Bacteremia During Acute Myeloid Leukemia (AML) Induction Therapy Is an Independent Predictor of Poor Outcome

Risk Factors for Vancomycin Resistant Enterococcus (VRE) Infection and Its Influence On Survival After Allogeneic Hematopoietic Progenitor Cell Transplantation (aHPCT)

Early Cessation of a Vancomycin-Resistant Enterococci (VRE) Outbreak in a Hematology-Oncology Department after Implementation of an Enhanced Infection Control Intervention. A Single Center Experience.

Email alerts

ASH Publications

American Society of Hematology

Secular Trends of Blood Stream Infections in the 72 Hours Prior to Death in Allogeneic Hematopoietic Cell Transplant Recipients

The Worth of Surveillance for Vancomycin-Resistant Enterococci in the Hematology-Oncology Unit

Vancomycin-Resistant Enterococcus (VRE) Bacteremia During Acute Myeloid Leukemia (AML) Induction Therapy Is an Independent Predictor of Poor Outcome

Risk Factors for Vancomycin Resistant Enterococcus (VRE) Infection and Its Influence On Survival After Allogeneic Hematopoietic Progenitor Cell Transplantation (aHPCT)

Early Cessation of a Vancomycin-Resistant Enterococci (VRE) Outbreak in a Hematology-Oncology Department after Implementation of an Enhanced Infection Control Intervention. A Single Center Experience.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only